Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Early Phase 1
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Early Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06477016Not ApplicableRecruiting

OsciPulse D-dimer Pilot Trial

Role: collaborator

NCT04625673Not ApplicableCompleted

OsciPulse Device for the Prevention of VTE

Role: collaborator

NCT05389488Phase 2Withdrawn

OsciPulse D-dimer Efficacy Trial

Role: lead

NCT05087108Early Phase 1Completed

Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow

Role: lead

All 4 trials loaded